News 12 Staff

•

Jul 17, 2023, 10:44 PM

•

Updated

More Stories

00:26

Want to support women-owned businesses? 5 ways to help you find shops during Women’s History Month

04:03

DEEP DIVE: Marking the 60th anniversary of Martin Luther King Jr.'s 'I Have a Dream' speech

04:02

Deep Dive: Retired superintendent shares insight on career and challenges in schools

03:42

Deep Dive: Juneteenth commemorations planned across New Jersey

03:32

Deep Dive: How wildfire smoke can have lasting effects on people

03:45

Deep Dive: Families of 9/11 victims condemn PGA for merger with LIV Golf

The FDA approved an antibody to protect newborns from RSV. 

It binds to the virus and blocks it from infecting health cells.

The antibody is not a vaccine for the respiratory virus: it is given as a single injection before RSV season, which usually peaks in the fall and winter.

News 12 spoke with Dr. Harpreet Pall, chair and professor of the Department of Pediatrics at Hackensack Meridian School of Medicine.

He discusses what the medical breakthrough means for parents.